Skip to content
Saturday, February 4, 2023
Latest:
  • Diabetes Health Type 2: Medication Keeping My Husband Out of The Bedroom
  • 12 Tips for Traveling With Diabetes
  • AskNadia: Exercising to Avoid Diabetes Complications
  • From the Sugar Happy Kitchen: Chicken Soup with Super Greens and 2.97 Net Carbs
  • Diabetes Health’s Resolution Versus Change With Your 2023 New Year’s Resolutions
Diabetes Health

Diabetes Health

Investigate. In form. Inspire

  • ASKNADIA
    • Books- Sugar Happy 1st Edition
    • Books And MP3
  • Sugar Happy Kitchen
  • CELEBRITIES
  • Diabetes Charts
  • Diabetes type
    • Type 1 Diabetes
    • Type 2 Diabetes
    • Gestational
    • Parent of Child with Diabetes
    • Family Member with Diabetes
    • Pre-Diabetes
    • Diabetes History
    • Diabetes Statistics – Symptoms and Prevention
  • Diabetes Care
    • A1c
    • Diabetes Complications
    • Blood Sugar
      • High Blood Sugar- Hyperglycemia
      • Low Blood Sugar- Hypoglcemia
    • Depression
    • Diabetes Cure
    • Diet
      • Recipes
      • Low Carb
      • Diets
      • Weight Loss
    • Exercise
    • Eye Care
    • Foot Care
    • Heart Care
    • Travel
    • Vitamins and Supplements
  • PODCAST
    • Podcast Interview
  • YouTube
  • Cartoon
    • Blood Sugar
    • Diet
    • Medical Device
    • Medication
    • Motivation
    • Mental Health
    • Travel
    • Holiday
    • Exercise
    • Misc
    • Small
  • SUBSCRIBE NOW!
    • ONLINE MAGAZINE
    • Subscribe Today
      • Buy A Gift Subscription
  • Shop Now
    • Diabetes Health Guides & Books
    • From the Sugar Happy Kitchen
      • Pantry Essentials
      • Kitchen Essentials
    • Diabetes Health & Sugar Happy Store
  • Contact Us
    • Contact Information
    • ABOUT
  • DONATE
  • Account details
  • Orders
  • Downloads

Fda

Astrazeneca Dapagliflozin Eli Lilly Fda Invokana News 

FDA Delays Final OK for Type 2 Drug Empagliflozin

March 23, 2014 Nadia Al-Samarrie 0 Comments

The FDA will delay allowing the type 2 drug empagliflozin to enter the U.S. market until “previously observed deficiencies” at

Read more
Blog Bydureon Byetta Fda Januvia Merck Novo Nordisk Victoza 

FDA Backtracks Over GLP-1s’ Effects on Pancreas

March 4, 2014 Nadia Al-Samarrie 0 Comments

The U.S. Food and Drug Administration reports that its review of various animal and human studies does not show a

Read more
Fda News 

More Than 180 New Diabetes Drugs in Development

March 1, 2014 Nadia Al-Samarrie 0 Comments

A total of 182 new drugs to treat diabetes or diabetes-related conditions are currently in clinical trials or undergoing review

Read more
Fda News 

FDA Approves Dexcom G4 Platinum CGM Use for Children 2-17

February 4, 2014 Nadia Al-Samarrie 0 Comments

The U.S. Food and Drug Administration has approved the expanded use of the Dexcom G4 Platinum Continuous Glucose Monitoring System

Read more
Fda News 

FDA Proposes Separate Guidelines for Home vs. Clinical Glucose Meters

January 23, 2014 Nadia Al-Samarrie 0 Comments

The Food and Drug Administration is proposing separate guidelines for over-the-counter blood glucose meters compared to those used at the

Read more
Fda News Type 1 

Type 1 Drug Wins Orphan Status

January 16, 2014 Nadia Al-Samarrie 0 Comments

DV-100, a drug designed to halt the body’s autoimmune attack on pancreatic beta cells that leads to type 1 disease,

Read more
Fda News 

FDA Opens Way for Diabetic Macular Edema Device

January 1, 2014 Nadia Al-Samarrie 0 Comments

The Food and Drug Adminsitration, reversing itself on a decision it made in October, has opened the way for a

Read more
Fda News 

Is High Fructose Corn Syrup “the New Trans Fat”?

December 13, 2013 Nadia Al-Samarrie 0 Comments

The non-profit consumer action group Citizens for Health earlier this month called on the Food and Drug Administration to do

Read more
Fda Insulin Pen News Novo Nordisk 

FDA Clears Novo’s Kid-Friendly Insulin Pen

August 22, 2013 Nadia Al-Samarrie 0 Comments

The U.S. Food and Drug Administration has granted 510(k) clearance for the NovoPen Echo®, the first insulin injection device on

Read more
Fda News 

FDA Tells 15 Companies to Stop Illegal Diabetes Treatment Sales

July 27, 2013 Nadia Al-Samarrie 0 Comments

The U.S. Food and Drug Administration has announced that it has issued letters warning 15 U.S. and foreign companies to

Read more
Fda Invokana News Sglt2 Inhibitors Type 2 

FDA Approves Invokana, a New Type 2 Drug

June 27, 2013 Nadia Al-Samarrie 0 Comments

A new, first-in-its-class drug for type 2 diabetes has just been approved by the Food and Drug Administration. Invokana works

Read more
  1. Pages:
  2. «
  3. 1
  4. 2
  5. 3
  6. 4
  7. 5
  8. »
  • ← Previous
  • Next →

Sign up To Our Newsletter

Loading

You Are Not Always at Fault for a High Blood Sugar Reading

https://www.diabeteshealth.com/wp-content/uploads/2022/06/bloodsugar.mp4

AskNadia

AskNadia: Exercising to Avoid Diabetes Complications
AskNadia Blog Blood Sugar Complications & Care Exercise 

AskNadia: Exercising to Avoid Diabetes Complications

January 4, 2023January 4, 2023 Nadia Al-Samarrie 0

Dear Nadia: I know I need to exercise to avoid diabetes complications. I just can’t get motivated to get going.

AskNadia: Struggling With Type 2 Diabetes and My A1C
A1c Level AskNadia Blog Depression Diabetes Diabetes Health 

AskNadia: Struggling With Type 2 Diabetes and My A1C

October 15, 2022October 15, 2022 Nadia Al-Samarrie 0
AskNadia: What is Considered a Good A1C Range?
American Association Of Clinical Endocrinologists Ask Nadia AskNadia Blood Glucose Blood Glucose Meter Blood Glucose Reading Blood Glucose Test Diabetes Health Hemoglobin Type 2 

AskNadia: What is Considered a Good A1C Range?

June 27, 2022July 26, 2022 Nadia Al-Samarrie 3
AskNadia: How to Bring Down A 434 Blood Sugar?
A1c Levels AskNadia Blood Glucose Reading Diabetes High Blood Sugar Insulin Medication Type1 Type2 

AskNadia: How to Bring Down A 434 Blood Sugar?

May 2, 2022March 29, 2022 Nadia Al-Samarrie 0

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.

 

Diabetes Health Magazine PO Box 1199, Woodacre CA 94973-1199

Copyright 2023 – Diabetes Health All right reserved

Copyright © 2023 Diabetes Health. All rights reserved.
Theme: ColorMag by ThemeGrill. Powered by WordPress.